Patent · US Active

Anti-ανβ6 antibodies

US9745376B2 · kind B2 · utility

1Cited by

56References

8Claims

0Family size

Assignees

Biogen MA Inc. · US
The Regents of the University of California · US

Inventors

Shelia M. Violette · Lexington, US
Paul H. Weinreb · Andover, US
Kenneth J. Simon · Cambridge, US
Dean Sheppard · Oakland, US
Diane R. Leone · Winchester, US

Key dates

Filing date	Jul 28, 2014
Grant date	Aug 29, 2017
Priority date	—
Expiry date	Jul 28, 2034

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/205
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Monoclonal antibodies that specifically bind to M.96. Also included are methods of using these antibodies to treat mammals having or at risk of having 006-mediated diseases, or to diagnose % Qmediated diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.